跳至主要内容
临床试验/CTRI/2020/02/023092
CTRI/2020/02/023092尚未招募未知

Identifying association of gene polymorphism and Prakriti in responders and non responders to dual antiplatelet therapy in coronary artery disease patients

A0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
A

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. North Indian ethnicity
  • 2. CAD patients (stable angina, non ST elevation and ST elevation myocardial infarction) presenting to Cardiology OPD, AIIMS after 30days of PCI up to 180 days
  • 3. Patients receiving dual antiplatelet therapy and on stable dose of clopidogrel upto 150 mg once a day and aspirin upto 150 mg once a day for a minimum period of 30 days
  • 4. Willing to participate in the study

排除标准

  • 1. Patients under anti coagulation therapy
  • 2. Use of intensified antiplateletagents other than standard dual antiplatelet therapy
  • 3. h/o Bleeding disorders (Hemophilia, von Willebrand disease), hospitalization related to bleeding
  • 4. Chronic kidney disease (eGFR < 60 ml/min)
  • 5. Any contraindications if elicited to antiplatelet therapy
  • 6. Patients with hemoglobin < 10
  • 7. Patients with platelet count < 100K
  • 8. Patients with major surgery within 1 week
  • 9. Patients with regular need of NSAID or prednisone(not taken in past 2 weeks)
  • 10. Females with pregnancy or lactation

研究者

发起方
A

相似试验